secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2026-09-17T01:03:10+00:00
Accession:  0001193125-26-393462
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics reduces stockholder quorum requirement to one-third of voting power
--------------------------------------------------------------------------------

- Board adopted Second Amended and Restated By-Laws effective September 16, 2026.
- Quorum for stockholder meetings lowered from majority to one-third of outstanding voting power.
- Board and committee quorum unchanged at majority.
- Amendment includes conforming, clarifying, and non-substantive changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000119312526393462/0001193125-26-393462-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000119312526393462/tcrt-20260916.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-393462

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer